Physician profile
Allison Wright
NPI 1952937989
$7,509.78
in general payments reported to CMS, 2019-2025
34 companies · $936 in 2025
The $936 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,699 · 2022: $2,279 · 2023: $930 · 2024: $666 · 2025: $936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,532.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,050.99 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $551.01 | 2021-2025 | Trintellix |
| Lundbeck LLC | $491.67 | 2021-2025 | Rexulti |
| Harmony Biosciences LLC | $479.85 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $477.45 | 2021-2024 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $444.69 | 2021-2024 | Rexulti |
| Neurocrine Biosciences, INC. | $418.18 | 2021-2025 | Ingrezza |
| Axsome Therapeutics, INC. | $288.58 | 2023-2025 | Auvelity |
| Supernus Pharmaceuticals, INC. | $267.67 | 2021-2025 | Qelbree |
| Jazz Pharmaceuticals INC. | $265.08 | 2021-2022 | |
| Alkermes, INC. | $227.09 | 2021-2025 | Lybalvi |
| Amgen INC. | $214.61 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $191.46 | 2021 | |
| Corium, LLC | $158.02 | 2023-2025 | Azstarys |
| Janssen Pharmaceuticals, INC | $136.97 | 2022-2025 | Spravato |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $104.45 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $98.10 | 2021 | |
| Neos Therapeutics, Lp | $82.64 | 2024-2025 | Adzenys Xr-Odt |
| Vanda Pharmaceuticals INC. | $67.69 | 2025 | Fanapt |
| Lilly USA, LLC | $51.61 | 2022 | |
| Merck Sharp & Dohme LLC | $50.73 | 2022 | |
| Avanir Pharmaceuticals, INC. | $49.87 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $41.65 | 2025 | Cobenfy |
| Collegium Pharmaceutical, INC. | $39.52 | 2025 | Jornay Pm |
| Acadia Pharmaceuticals INC | $38.92 | 2021 | |
| Eisai INC. | $38.11 | 2021 | |
| Noven Therapeutics, LLC | $36.24 | 2021 | |
| Owp Pharmaceuticals, INC. | $34.82 | 2021 | |
| Alfasigma USA, INC. | $29.75 | 2021 | |
| Tms Neurohealth Centers INC. | $23.58 | 2025 | Tms Neurohealth Centers INC. |
| Noven Pharmaceuticals, INC. | $15.74 | 2021 | |
| Currax Pharmaceuticals LLC | $15.49 | 2021 | |
| Adlon Therapeutics L.P. | $14.53 | 2021 | |
| Grifols USA, LLC | $13.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.